Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer.
Autor: | Liu, Yan-cui MM, Ma, Ying MM, An, Ning MM, Sun, Ping MD, Wang, Ying MD, Sun, Cheng MB |
---|---|
Zdroj: | Medicine; 9/20/2019, Vol. 98 Issue 38, pe17262-e17262, 1p |
Databáze: | Complementary Index |
Externí odkaz: |